Performance

GPCR -34.81%

Watchlist

Select an item

RETURNS	1D	YTD	1Y	5Y Ann.	Max DD	Sharpe	Div. Yield
GPCR	+5.21%	-69.22%	-34.81%	—	-79.66%	0.03	0.00%

Summary

GPCR at a glance

GPCR returned -34.81% over the past year. Its worst drop in that year was -79.66%, smaller than 2% of stocks on Redstone, and its Sharpe ratio of 0.03 beats 28% of stocks on Redstone. It pays no dividends.

Ranking

How GPCR ranks

Current Drawdown

-77.17%

Rolling Volatility

62.65%

Actions

Metrics

Risk Indicators

Alpha-8.50%

Beta1.22x

Sharpe0.03

Sortino0.08

Omega1.01

Calmar-0.44

Martin0.08

Profile

About GPCR

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs.

Sector: Health Care
Industry: Pharmaceutical Preparations
Market cap: $1.5B
Listed: Feb 2023
Employees: 281
Headquarters: South San Francisco, CA
Website: structuretx.com

Comparisons

GPCR: Structure Therapeutics Inc.

GPCR at a glance

How GPCR ranks

Current Drawdown

Rolling Volatility

About GPCR

Related comparisons